Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Lymphoid 1

Conditions

Lymphoma 159Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Leukemia 72Lymphoma, Large B-Cell, Diffuse 61Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55Lymphoma, Follicular 48Lymphoma, Non-Hodgkin 43Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Anaplastic 32Leukemia, Myeloid, Acute 27Lymphoma, B-Cell, Marginal Zone 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Biphenotypic, Acute 24Waldenstrom Macroglobulinemia 23Recurrence 21Lymphoma, T-Cell, Cutaneous 21Mycosis Fungoides 18Dendritic Cell Sarcoma, Interdigitating 18Sezary Syndrome 16Immunoblastic Lymphadenopathy 14Myelodysplastic Syndromes 13Leukemia, Myelomonocytic, Juvenile 13Leukemia, Myelomonocytic, Chronic 13Central Nervous System Neoplasms 13Myeloproliferative Disorders 12Multiple Myeloma 12Blast Crisis 12

Interventions

Specimen Handling 1Fluid Therapy 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Diffuse Intrinsic Pontine Glioma × Lymphoid × Clear all
NCT04870944 2026-05-05

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Children's Oncology Group

Phase 1/2 Recruiting
63 enrolled
CNSLymphoid

Diffuse Intrinsic Pontine Glioma, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡